Auricular Acupuncture in Substance Abuse: Effects on Anxiety, Sleep, Drug Use.
NCT02604706 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 280
Last updated 2015-11-16
Summary
Background. A common alternative treatment for substance abuse is ear acupuncture. The aim of the study was to evaluate the short and long-term effect of auricular acupuncture on anxiety, sleep, drug use and addiction treatment utilization in adults with substance abuse. Method. Adults with substance abuse and psychiatric comorbidity were randomly assigned to either of two variants of auricular acupuncture - The National Acupuncture Detoxification Association protocol (NADA) or a local protocol (LP) - or relaxation training (controls). Primary outcomes were measured using the Beck Anxiety Inventory (BAI) and Insomnia Severity Index (ISI) with assessment before treatment and follow-ups after five weeks and three months. Secondary outcomes were drug use and addiction service utilization.
Conditions
- Substance Abuse
- Anxiety
- Sleep
Interventions
- DEVICE
-
NADA Acupuncture
NADA-acupuncture was delivered in three phases: (1) one treatment each day during the first of a total of five weeks; (2) three treatments each week during the following two weeks; (3) two treatments each week during the two remaining weeks. each session consisted of approximately 40 minutes with acupuncture at five ear points called Sympathetic, Shen Men, Kidney, Liver and Lung, which are believed to be the best points for substance abuse patients. Acupuncture was administered to both ears using stainless steel needles. NADA-acupuncture were given as a supplement to treatment as usual consisting of Motivational Interview, pharmacological treatment, and control of drug use with urine tests.
- DEVICE
-
LP acupuncture
The LP-acupuncture was delivered in two phases: (1) three treatments each week during the two first weeks; (2) two treatments each week for two weeks. each session consisted of approximately 40 minutes with acupuncture at five ear points called Sympathetic, Shen Men, Kidney, Liver and Lung, which are believed to be the best points for substance abuse patients. Acupuncture was administered to both ears using stainless steel needles. LP-acupuncture were given as a supplement to treatment as usual consisting of Motivational Interview, pharmacological treatment, and control of drug use with urine tests.
- BEHAVIORAL
-
Relaxation
Relaxation consisted of listening to soft music in a quiet room with dampened light and was delivered to match the amount and phases of the LP-acupuncture. Relaxation were given as a supplement to treatment as usual consisting of Motivational Interview, pharmacological treatment, and control of drug use with urine tests.
Sponsors & Collaborators
-
Örebro Läns Landsting
lead OTHER_GOV
Principal Investigators
-
Rickard Ahlberg · Örebro Läns Landsting
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- Sweden
Study Locations
More Related Trials
-
Pilot Evaluation of the Empower Neuromodulation System in AUD Patients
NCT03983317 ·Status: COMPLETED ·Phase: NA
-
Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment of Substance Use Disorders
NCT03114423 ·Status: UNKNOWN ·Phase: NA
-
A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
NCT05621538 ·Status: RECRUITING ·Phase: NA
-
Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence
NCT01014533 ·Status: COMPLETED ·Phase: NA
-
Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal
NCT04159909 ·Status: WITHDRAWN ·Phase: NA
-
Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.
NCT02068261 ·Status: UNKNOWN ·Phase: PHASE2
-
Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder
NCT06959342 ·Status: RECRUITING ·Phase: NA
-
Using Aromatherapy in Substance Use Disorder
NCT05660434 ·Status: COMPLETED ·Phase: NA
-
Anxiety During Abstinence in AUD
NCT06793488 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Eye Movement Desensitization and Reprocessing as a Treatment for Substance Use Disorders
NCT05488691 ·Status: COMPLETED ·Phase: NA
-
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
NCT00453804 ·Status: COMPLETED ·Phase: PHASE4
-
Neurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use Disorder
NCT04897295 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
NCT02667015 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Neuromodulation Technologies in Early Recovery
NCT01993277 ·Status: UNKNOWN ·Phase: NA
-
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
NCT00453609 ·Status: COMPLETED ·Phase: PHASE4
-
Oxytocin in Alcohol Use Disorder
NCT02711189 ·Status: WITHDRAWN ·Phase: PHASE1
-
Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence
NCT00435435 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
NCT00614328 ·Status: COMPLETED ·Phase: PHASE1
-
Neuromodulation and Mindfulness Patients With AUD
NCT06308484 ·Status: RECRUITING ·Phase: NA
-
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
NCT06969937 ·Status: RECRUITING ·Phase: PHASE2
-
Single and Dual Task Balance Exercises in Substance Use Disorders
NCT05944536 ·Status: UNKNOWN ·Phase: NA
-
Addictions Neuroclinical Assessment (ANA)
NCT04946851 ·Status: ENROLLING_BY_INVITATION
-
Intranasal Oxytocin for the Treatment of Alcohol Use Disorder
NCT03878316 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Treatment of Alcohol Dependence
NCT02275611 ·Status: COMPLETED ·Phase: PHASE2
-
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
NCT02407340 ·Status: COMPLETED ·Phase: PHASE1